JUNSHI BIO (688180.SH): Shanghai Tan Ying plans to reduce its shareholding by no more than 2%
Junshi Biosciences (688180.SH) announced that Shanghai Tan Ying is optimistic about the company's long-term development. Due to the fund's tenure and liquidity arrangements, it plans to reduce its holding of the company's shares through block trading by no more than 20,533,800 shares, with the reduction not exceeding 2% of the total share capital.
JUNSHI BIO (688180.SH) announced that Shanghai Tan Ying is optimistic about the company's long-term development. Due to fund term and liquidity arrangements, they plan to reduce their holdings in the company by no more than 20.53 million shares through block trades, with a reduction ratio not exceeding 2% of the total share capital of the company.
Related Articles

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


